Drugs Health Medical

Pfizer’s trial antibody for type of bladder cancer meets main goal

Pizer Inc.’s late-stage trial of an antibody treatment for a certain type of bladder cancer has shown significant improvement in time patients remained.

Read More
Drugs Health Research

Effects of loneliness, social isolation leave their mark on blood: Cambridge study

Loneliness may contribute to a higher risk of heart disease, stroke and susceptibility to infections, according to a study conducted by the University.

Read More
Drugs Health Medical

China approves Merck’s human papillomavirus jab for use in males 

China has approved Merck & Co.’s human papillomavirus vaccine for males between nine and 26 years amid a fall in sales for the.

Read More
Drugs Health Medical

Novo Nordisk, Valo expand pact to include obesity, diabetic drugs

Novo Nordisk A/S, a Danish pharmaceutical company, has expanded its agreement with US-based Valo Health Inc., almost to double the number of drugs.

Read More
Drugs Health Medical

Respiratory infections in China have no ‘unusual outbreak patterns’

A rise in cases of respiratory infections in China is within the expected range during this time of the year, and the World.

Read More
Drugs Health Medical Pharma

J&J’s combination extends lives of cancer patients versus rival drug

Johnson & Johnson’s combination therapy for treating a certain form of cancer without chemotherapy, has been shown to extend patients' lives by more.

Read More
Drugs Health Medical

Dancing can help lower depression in people with Parkinson’s disease

Dancing has a positive effect on the “mood circuits” in the brain and can lower depression in people with Parkinson’s disease, according to.

Read More
Drugs Medical Pharma

WuXi Biologics sells global rights to cancer antibody to Candid for $925m

China’s WuXi Biologics, a clinical research organization, has granted global rights to US-based Candid Therapeutics to use the company’s synthetic antibody to fight.

Read More
Drugs Medical Pharma

Stryker to buy Inari for $4.9b to expand neurovascular business

US-based medical device maker Stryker Corporation will acquire Inari Medical Inc., for about $4.9 billion to expand the former’s neurovascular business.

Read More
Drugs Medical Research

Genetic testing offers hope against deadly C. auris infections

HQ Team January 4, 2025: A new study reveals that genetic testing can identify which antifungal drugs will effectively treat patients with Candida.

Read More